Irwin Naturals, Inc.
Irwin Naturals, Inc. engages in the development and distribution of vitamins and other health supplements in the United States, Canada, and internationally. The company offers CBD oils, gummies, soft gels, CBD creams, balms and roll-ons, vitamins and supplements, topicals, and other products. It also operates mental health clinics. The company sells its products through health food stores and mas… Read more
Irwin Naturals, Inc. (IWINQ) - Net Assets
Latest net assets as of September 2023: $13.88 Million USD
Based on the latest financial reports, Irwin Naturals, Inc. (IWINQ) has net assets worth $13.88 Million USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($70.86 Million) and total liabilities ($56.97 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $13.88 Million |
| % of Total Assets | 19.59% |
| Annual Growth Rate | 43.26% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 12.7 |
Irwin Naturals, Inc. - Net Assets Trend (2020–2022)
This chart illustrates how Irwin Naturals, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Irwin Naturals, Inc. (2020–2022)
The table below shows the annual net assets of Irwin Naturals, Inc. from 2020 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $30.30 Million | +31.09% |
| 2021-12-31 | $23.12 Million | +56.49% |
| 2020-12-31 | $14.77 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Irwin Naturals, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 332400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $26.52 Million | 114.33% |
| Total Equity | $23.20 Million | 100.00% |
Irwin Naturals, Inc. Competitors by Market Cap
The table below lists competitors of Irwin Naturals, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Silly Monks Entertainment Limited
NSE:SILLYMONKS
|
$736.66K |
|
Goldflare Exploration Inc
V:GOFL
|
$737.13K |
|
Lehto Group Oyj
F:L7G
|
$737.47K |
|
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO
|
$737.52K |
|
Adex Mining Inc
PINK:ADXDF
|
$736.47K |
|
PRINCIPAL FINANCIAL - Dusseldorf Stock Exchang
DU:PG4
|
$735.67K |
|
MAN vz. (Pref Shares)
STU:MAN3
|
$735.28K |
|
GO2 People Ltd
AU:GO2
|
$734.82K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Irwin Naturals, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 17,481,000 to 23,196,000, a change of 5,715,000 (32.7%).
- Net loss of 3,992,000 reduced equity.
- Share repurchases of 56,000 reduced equity.
- Other factors increased equity by 9,763,000.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.99 Million | -17.21% |
| Share Repurchases | $56.00K | -0.24% |
| Other Changes | $9.76 Million | +42.09% |
| Total Change | $- | 32.69% |
Book Value vs Market Value Analysis
This analysis compares Irwin Naturals, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.04x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $12.13 | $0.28 | x |
| 2021-12-31 | $14.35 | $0.28 | x |
| 2022-12-31 | $7.72 | $0.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Irwin Naturals, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -17.21%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.46%
- • Asset Turnover: 1.14x
- • Equity Multiplier: 3.40x
- Recent ROE (-17.21%) is below the historical average (27.03%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 49.01% | 8.10% | 2.45x | 2.47x | $5.76 Million |
| 2021 | 49.28% | 8.59% | 2.13x | 2.70x | $6.87 Million |
| 2022 | -17.21% | -4.46% | 1.14x | 3.40x | $-6.31 Million |
Industry Comparison
This section compares Irwin Naturals, Inc.'s net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Irwin Naturals, Inc. (IWINQ) | $13.88 Million | 49.01% | 4.10x | $736.49K |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |